SKIN AS A POTENTIAL ENTRY POINT FOR SARS-COV-2

This study demonstrates that inflammatory cytokines associated with skin diseases and severe COVID-19 upregulate viral entry receptors (ACE2 and TMPRSS2) in human skin models, thereby significantly enhancing SARS-CoV-2 susceptibility and suggesting the skin is a previously underappreciated potential entry point for the virus.

The Gist

Imagine your body as a massive, fortified castle. For a long time, we thought the only way the SARS-CoV-2 virus (the "invader") could get inside was through the main gate: your nose and lungs. But this new research suggests the castle has a secret, often overlooked back door: your skin.

Here is the story of what the scientists discovered, broken down into simple terms:

1. The "Back Door" Theory

We know the virus usually enters through breathing. However, doctors noticed that many people with COVID-19 also got weird rashes and skin sores. The virus's genetic code was even found hiding in their skin. This made scientists wonder: Could the skin actually be a way for the virus to get in, not just a place it ends up?

2. Building a "Mini-Skin" Lab

To test this without hurting real people, the researchers built 3D "mini-skins" in a lab. Think of these as tiny, perfect replicas of human skin grown from scratch. They also used actual samples of baby skin to double-check their results.

3. The "Inflammation" Alarm

The key discovery here is about inflammation. You know how your skin gets red, hot, and itchy when you have a bad sunburn, eczema, or psoriasis? That's inflammation. In severe COVID cases, the body also goes into a massive "cytokine storm," which is like a fire alarm going off everywhere in the body.

The scientists took their mini-skins and "faked" this inflammation by adding chemical signals (cytokines) that mimic:

• A bad sunburn or allergy (Th2 inflammation).
• A severe infection or psoriasis flare-up (Th1 inflammation).
• A massive "cytokine storm" (a mix of all the alarms).

4. The "Doors" Open Wider

Your skin has special "locks" on its surface called ACE2 and TMPRSS2. The virus needs these locks to unlock the door and get inside.

• Normal Skin: The locks are there, but they are closed tight.
• Inflamed Skin: When the scientists added the inflammation chemicals, it was like someone shouting at the locks to "Open up!" The skin cells responded by building more locks and leaving the doors wide open.
  • Some types of inflammation (like psoriasis) opened the ACE2 door.
  • Other types (like allergies) opened the TMPRSS2 door.
  • The worst mix (the "cytokine storm") opened both doors wide.

5. The Test Drive

To see if the virus could actually get in, they didn't use the real, dangerous virus. Instead, they used a harmless "Trojan Horse"—a fake virus that looks exactly like SARS-CoV-2 on the outside but carries a glowing red light (Tomato reporter) inside.

• Result: When they dropped this fake virus on normal skin, it barely got in. But when they dropped it on the inflamed skin, it slipped right through the open doors and lit up the cells red! The inflamed skin was much more welcoming to the virus.

6. The Big Picture

The scientists also looked at the "instruction manuals" (genes) inside the infected skin. They found that the changes happening in the inflamed skin looked very similar to what happens in the lungs of severe COVID patients. This proves that their mini-skin models are realistic.

The Takeaway

This study suggests that inflamed skin is a VIP entry point for the virus. If your skin is already irritated, it has a bad rash, or you have a condition like eczema or psoriasis, your skin might be more vulnerable to catching the virus, not just reacting to it.

In short: Think of your skin as a fortress wall. When it's healthy, the gates are locked. But when the wall is on fire (inflamed), the gates swing wide open, inviting the virus right in. This means taking care of your skin health might be an important, yet previously overlooked, part of staying safe from COVID-19.

Technical Summary

1. Problem Statement

While the respiratory epithelium is established as the primary entry point for SARS-CoV-2, clinical observations present a paradox: many COVID-19 patients develop dermatological lesions, and viral RNA has been detected in patient skin samples. Furthermore, patients with pre-existing inflammatory skin conditions, specifically psoriasis and atopic dermatitis (AD), exhibit a significantly increased risk of contracting COVID-19. The central scientific question addressed by this study is whether the skin acts as a viable, albeit underappreciated, entry point for the virus, and how the inflammatory state of the skin (mimicking cytokine storms or chronic dermatological conditions) influences viral susceptibility.

2. Methodology

The researchers employed a multi-faceted in vitro and ex vivo approach to model human skin under various inflammatory conditions:

• Model Systems:
  • 3D Human Skin Organoids (HSO): Generated from human epidermal keratinocytes to mimic the complex architecture of human skin.
  • Neonatal Skin Explants: Used to validate findings in native tissue structures.
• Inflammatory Stimuli:
  • Cytokine Cocktails: HSOs were treated with individual cytokines associated with acute/chronic inflammation and the "cytokine storm" seen in severe COVID-19: TNF-α, IL-6, IL-1β, and IFN-γ.
  • Disease-Specific Models:
    • Th1 Cocktail (TNF-α + IL-17): Induced pro-psoriasis changes.
    • Th2 Cocktail (IL-4 + IL-13): Induced pro-atopic dermatitis changes.
  • Combination Treatments: Specific combinations (e.g., TNF-α + IL-6 + IL-1β + IFN-γ) were used to simulate severe systemic inflammation.
• Viral Entry Assay:
  • A Spike-pseudotyped lentiviral Tomato reporter was used. This vector binds to ACE2 similarly to SARS-CoV-2 but does not replicate, allowing for safe quantification of viral entry.
• Analytical Techniques:
  • Molecular Biology: Quantification of ACE2 and TMPRSS2 expression at both mRNA and protein levels.
  • Transcriptomics: RNA sequencing to analyze gene expression signatures.
  • Comparative Analysis: Comparison of skin-derived gene signatures with existing lung tissue data from COVID-19 patients.

3. Key Contributions

• Establishment of a Skin-Specific Infection Model: The study successfully utilized 3D HSOs and neonatal explants to demonstrate that human skin is permissive to SARS-CoV-2 entry, moving beyond the respiratory-centric view of the virus.
• Mechanistic Link Between Inflammation and Susceptibility: The paper provides a mechanistic explanation for why patients with inflammatory skin diseases are at higher risk, demonstrating that inflammation directly upregulates the viral entry machinery.
• Differentiation of Cytokine Effects: The study distinctively mapped how different inflammatory pathways (Th1 vs. Th2) differentially regulate the two critical viral entry receptors, ACE2 and TMPRSS2.

4. Key Results

• Upregulation of Entry Receptors: Treatment with individual cytokines, and particularly their combinations, significantly elevated the expression of ACE2 (the receptor) and TMPRSS2 (the protease required for spike protein priming) at both mRNA and protein levels.
• Differential Regulation by Inflammatory Pathways:
  • Th2 Conditions (Pro-AD): Induced an increase in TMPRSS2 only.
  • Th1 Conditions (Pro-Psoriasis): Predominantly induced ACE2.
  • Cytokine Storm Simulation: The combination of TNF-α, IL-6, IL-1β, and IFN-γ resulted in the most significant upregulation of both receptors.
• Enhanced Viral Entry:
  • The Spike-pseudotyped virus successfully infected both control and cytokine-treated HSOs and neonatal skin explants.
  • Quantitative Increase: Cytokine treatment, specifically the "cytokine storm" cocktail and the Th1 cocktail, significantly increased the rate of viral entry compared to untreated controls.
• Transcriptomic Validation: Gene expression analysis revealed a partial overlap between the signatures induced by Spike-mediated entry in inflamed skin organoids and those observed in the lung tissue of actual COVID-19 patients, confirming the biological relevance of the skin model.

5. Significance and Implications

This study fundamentally shifts the understanding of SARS-CoV-2 host interactions by identifying the skin as a previously underappreciated interface for viral entry.

• Clinical Relevance: The findings provide a biological basis for the increased susceptibility of patients with psoriasis and atopic dermatitis to COVID-19. It suggests that the local inflammatory environment creates a "fertile ground" for viral infection by upregulating necessary entry receptors.
• Therapeutic Insight: The results imply that managing skin inflammation (e.g., via cytokine modulation) could potentially reduce the risk of cutaneous viral entry or severity of infection in dermatological patients.
• Pathophysiological Understanding: By demonstrating that skin inflammation mimics the receptor upregulation seen in the lungs, the study supports the hypothesis that cutaneous manifestations in COVID-19 may not just be secondary immune responses but could, in some cases, represent a primary site of viral interaction or entry.